|
1
|
Meyer MA: Malignant gliomas in adults. N
Engl J Med. 359:1850author reply 1850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohgaki H and Kleihues P: Population-based
studies on incidence, survival rates, and genetic alterations in
astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol.
64:479–489. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bloom BR and Bennett B: Mechanism of a
reaction in vitro associated with delayed-type hypersensitivity.
Science. 153:80–82. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calandra T and Roger T: Macrophage
migration inhibitory factor: A regulator of innate immunity. Nat
Rev Immunol. 3:791–800. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Apte RS, Sinha D, Mayhew E, Wistow GJ and
Niederkorn JY: Cutting edge: Role of macrophage migration
inhibitory factor in inhibiting NK cell activity and preserving
immune privilege. J Immunol. 160:5693–5696. 1998.PubMed/NCBI
|
|
6
|
Daun JM and Cannon JG: Macrophage
migration inhibitory factor antagonizes hydrocortisone-induced
increases in cytosolic IkappaBalpha. Am J Physiol Regul Integr Comp
Physiol. 279:R1043–R1049. 2000.PubMed/NCBI
|
|
7
|
Bucala R and Donnelly SC: Macrophage
migration inhibitory factor: A probable link between inflammation
and cancer. Immunity. 26:281–285. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roger T, Chanson AL, Knaup-Reymond M and
Calandra T: Macrophage migration inhibitory factor promotes innate
immune responses by suppressing glucocorticoid-induced expression
of mitogen-activated protein kinase phosphatase-1. Eur J Immunol.
35:3405–3413. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meyer-Siegler KL, Iczkowski KA, Leng L,
Bucala R and Vera PL: Inhibition of macrophage migration inhibitory
factor or its receptor (CD74) attenuates growth and invasion of
DU-145 prostate cancer cells. J Immunol. 177:8730–8739. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bacher M, Eickmann M, Schrader J, Gemsa D
and Heiske A: Human cytomegalovirus-mediated induction of MIF in
fibroblasts. Virology. 299:32–37. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mitchell RA, Metz CN, Peng T and Bucala R:
Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic
phospholipase A2 activation by macrophage migration inhibitory
factor (MIF). Regulatory role in cell proliferation and
glucocorticoid action. J Biol Chem. 274:18100–18106. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bacher M, Schrader J, Thompson N, Kuschela
K, Gemsa D, Waeber G and Schlegel J: Up-regulation of macrophage
migration inhibitory factor gene and protein expression in glial
tumor cells during hypoxic and hypoglycemic stress indicates a
critical role for angiogenesis in glioblastoma multiforme. Am J
Pathol. 162:11–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lue H, Thiele M, Franz J, Dahl E,
Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B and
Bernhagen J: Macrophage migration inhibitory factor (MIF) promotes
cell survival by activation of the Akt pathway and role for
CSN5/JAB1 in the control of autocrine MIF activity. Oncogene.
26:5046–5059. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rabinowitz JD and White E: Autophagy and
metabolism. Science. 330:1344–1348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shintani T and Klionsky DJ: Autophagy in
health and disease: A double-edged sword. Science. 306:990–995.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aita VM, Liang XH, Murty VV, Pincus DL, Yu
W, Cayanis E, Kalachikov S, Gilliam TC and Levine B: Cloning and
genomic organization of beclin 1, a candidate tumor suppressor gene
on chromosome 17q21. Genomics. 59:59–65. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi AM, Ryter SW and Levine B: Autophagy
in human health and disease. N Engl J Med. 368:1845–1846. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo JY, Xia B and White E:
Autophagy-mediated tumor promotion. Cell. 155:1216–1219. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hall A: The cytoskeleton and cancer.
Cancer Metastasis Rev. 28:5–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsui T, Amano M, Yamamoto T, Chihara K,
Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A and Kaibuchi K:
Rho-associated kinase, a novel serine/threonine kinase, as a
putative target for small GTP binding protein Rho. EMBO J.
15:2208–2216. 1996.PubMed/NCBI
|
|
23
|
Leung T, Manser E, Tan L and Lim L: A
novel serine/threonine kinase binding the Ras-related RhoA GTPase
which translocates the kinase to peripheral membranes. J Biol Chem.
270:29051–29054. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Amano M, Chihara K, Kimura K, Fukata Y,
Nakamura N, Matsuura Y and Kaibuchi K: Formation of actin stress
fibers and focal adhesions enhanced by Rho-kinase. Science.
275:1308–1311. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Riento K and Ridley AJ: Rocks:
Multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol.
4:446–456. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Amano M, Nakayama M and Kaibuchi K:
Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell
polarity. Cytoskeleton Hoboken. 67:545–554. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Banchereau J and Steinman RM: Dendritic
cells and the control of immunity. Nature. 392:245–252. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lai A, Tran A, Nghiemphu PL, Pope WB,
Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, et al:
Phase II study of bevacizumab plus temozolomide during and after
radiation therapy for patients with newly diagnosed glioblastoma
multiforme. J Clin Oncol. 29:142–148. 2011. View Article : Google Scholar :
|
|
29
|
Ghulam Muhammad AK, Candolfi M, King GD,
Yagiz K, Foulad D, Mineharu Y, Kroeger KM, Treuer KA, Nichols WS,
Sanderson NS, et al: Antiglioma immunological memory in response to
conditional cytotoxic/immune-stimulatory gene therapy: Humoral and
cellular immunity lead to tumor regression. Clin Cancer Res.
15:6113–6127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Perng P and Lim M: Immunosuppressive
mechanisms of malignant gliomas: Parallels at non-CNS sites. Front
Oncol. 5:1532015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Van Gool S, Maes W, Ardon H, Verschuere T,
Van Cauter S and De Vleeschouwer S: Dendritic cell therapy of
high-grade gliomas. Brain Pathol. 19:694–712. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shao Q, Ning H, Lv J, Liu Y, Zhao X, Ren
G, Feng A, Xie Q, Sun J, Song B, et al: Regulation of Th1/Th2
polarization by tissue inhibitor of metalloproteinase-3 via
modulating dendritic cells. Blood. 119:4636–4644. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Laperchia C, Allegra Mascaro AL, Sacconi
L, Andrioli A, Mattè A, De Franceschi L, Grassi-Zucconi G,
Bentivoglio M, Buffelli M and Pavone FS: Two-photon microscopy
imaging of thy1GFP-M transgenic mice: A novel animal model to
investigate brain dendritic cell subsets in vivo. PLoS One.
8:e561442013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Coventry BJ, Austyn JM, Chryssidis S,
Hankins D and Harris A: Identification and isolation of CD1a
positive putative tumour infiltrating dendritic cells in human
breast cancer. Adv Exp Med Biol. 417:571–577. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang XB, Tian XY, Li Y, Li B and Li Z:
Elevated expression of macrophage migration inhibitory factor
correlates with tumor recurrence and poor prognosis of patients
with gliomas. J Neurooncol. 106:43–51. 2012. View Article : Google Scholar
|
|
36
|
Ghoochani A, Schwarz MA, Yakubov E,
Engelhorn T, Doerfler A, Buchfelder M, Bucala R, Savaskan NE and
Eyüpoglu IY: MIF-CD74 signaling impedes microglial M1 polarization
and facilitates brain tumorigenesis. Oncogene. May 9–2016.(Epub
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fukaya R, Ohta S, Yaguchi T, Matsuzaki Y,
Sugihara E, Okano H, Saya H, Kawakami Y, Kawase T, Yoshida K, et
al: MIF maintains the tumorigenic capacity of brain
tumor-initiating cells by directly inhibiting p53. Cancer Res.
76:2813–2823. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xue H, Yuan G, Guo X, Liu Q, Zhang J, Gao
X, Guo X, Xu S, Li T, Shao Q, et al: A novel tumor-promoting
mechanism of IL6 and the therapeutic efficacy of tocilizumab:
Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma
via the p-STAT3-MIR155-3p-CREBRF pathway. Autophagy. 12:1129–1152.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu R, Li J, Zhang T, Zou L, Chen Y, Wang
K, Lei Y, Yuan K, Li Y, Lan J, et al: Itraconazole suppresses the
growth of glioblastoma through induction of autophagy: Involvement
of abnormal cholesterol trafficking. Autophagy. 10:1241–1255. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu MY, Fu J, Xu J, O'Malley BW and Wu RC:
Steroid receptor coactivator 3 regulates autophagy in breast cancer
cells through macrophage migration inhibitory factor. Cell Res.
22:1003–1021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lai YC, Chuang YC, Chang CP and Yeh TM:
Macrophage migration inhibitory factor has a permissive role in
concanavalin A-induced cell death of human hepatoma cells through
autophagy. Cell Death Dis. 6:e20082015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chuang YC, Su WH, Lei HY, Lin YS, Liu HS,
Chang CP and Yeh TM: Macrophage migration inhibitory factor induces
autophagy via reactive oxygen species generation. PLoS One.
7:e376132012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu X, Hua Y, Nair S, Bucala R and Ren J:
Macrophage migration inhibitory factor deletion exacerbates
pressure overload-induced cardiac hypertrophy through mitigating
autophagy. Hypertension. 63:490–499. 2014. View Article : Google Scholar :
|
|
44
|
Leng L, Metz CN, Fang Y, Xu J, Donnelly S,
Baugh J, Delohery T, Chen Y, Mitchell RA and Bucala R: MIF signal
transduction initiated by binding to CD74. J Exp Med.
197:1467–1476. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shi X, Leng L, Wang T, Wang W, Du X, Li J,
McDonald C, Chen Z, Murphy JW, Lolis E, et al: CD44 is the
signaling component of the macrophage migration inhibitory
factor-CD74 receptor complex. Immunity. 25:595–606. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bernhagen J, Krohn R, Lue H, Gregory JL,
Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, et
al: MIF is a noncognate ligand of CXC chemokine receptors in
inflammatory and atherogenic cell recruitment. Nat Med. 13:587–596.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rendon BE, Roger T, Teneng I, Zhao M,
Al-Abed Y, Calandra T and Mitchell RA: Regulation of human lung
adenocarcinoma cell migration and invasion by macrophage migration
inhibitory factor. J Biol Chem. 282:29910–29918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sun B, Nishihira J, Yoshiki T, Kondo M,
Sato Y, Sasaki F and Todo S: Macrophage migration inhibitory factor
promotes tumor invasion and metastasis via the Rho-dependent
pathway. Clin Cancer Res. 11:1050–1058. 2005.PubMed/NCBI
|
|
49
|
Gurkar AU, Chu K, Raj L, Bouley R, Lee SH,
Kim YB, Dunn SE, Mandinova A and Lee SW: Identification of ROCK1
kinase as a critical regulator of Beclin1-mediated autophagy during
metabolic stress. Nat Commun. 4:21892013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang P, Lu Y, Liu XY and Zhou YH:
Knockdown of Rho-associated protein kinase 1 suppresses
proliferation and invasion of glioma cells. Tumour Biol.
36:421–428. 2015. View Article : Google Scholar
|
|
51
|
Huang D, Qiu S, Ge R, He L, Li M, Li Y and
Peng Y: miR-340 suppresses glioblastoma multiforme. Oncotarget.
6:9257–9270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mittelbronn M, Platten M, Zeiner P,
Dombrowski Y, Frank B, Zachskorn C, Harter PN, Weller M and
Wischhusen J: Macrophage migration inhibitory factor (MIF)
expression in human malignant gliomas contributes to immune escape
and tumour progression. Acta Neuropathol. 122:353–365. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Otvos B, Silver DJ, Mulkearns-Hubert EE,
Alvarado AG, Turaga SM, Sorensen MD, Rayman P, Flavahan WA, Hale
JS, Stoltz K, et al: Cancer stem cell-secreted macrophage migration
inhibitory factor stimulates myeloid derived suppressor cell
function and facilitates glioblastoma immune evasion. Stem Cells.
34:2026–2039. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Etminan N, Peters C, Lakbir D, Bünemann E,
Börger V, Sabel MC, Hänggi D, Steiger HJ, Stummer W and Sorg RV:
Heat-shock protein 70-dependent dendritic cell activation by
5-aminolevulinic acid-mediated photodynamic treatment of human
glioblastoma spheroids in vitro. Br J Cancer. 105:961–969. 2011.
View Article : Google Scholar : PubMed/NCBI
|
